The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
Creator
Wilson, Carolyn A.
Cichutek, Klaus
Bibliographic Citation
Methods in Molecular Biology 2009; 506: 477-488
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Barcoding of Macaque Hematopoietic Stem and Progenitor Cells: A Robust Platform to Assess Vector Genotoxicity
Yabe, Idalia (Georgetown University, 2019)Gene therapies using integrating retroviral vectors to modify hematopoietic stem and progenitor cells have shown great promise for treatment of immune system and hematologic diseases. However, activation of proto-oncogenes ...